A global spike in demand for respiratory humidifiers and devices used in ventilation treatments for hospital patients has triggered a profit upgrade for Fisher & Paykel Healthcare, which has ramped up ...

Fisher & Paykel is well-positioned to benefit from the long-term growth prospects in hospital and home respiratory care. Widespread adoption of what management terms “new applications” in the ...

Fisher & Paykel Healthcare Limited designs, manufactures, and markets products for respiratory care, acute care, and obstructive sleep apnea. The company primarily operates in three business segments: ...

Dec 12 (Reuters) - New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate ...

Fisher & Paykel Healthcare Corp Ltd (FSPKF) recently announced a dividend of $0.18 per share, payable on 2023-12-18, with the ex-dividend date set for 2023-12-05. As investors look forward to this ...

Prominent players in the Medical humidifier market include, include ResMed Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Koninklijke Philips N.V.